0.00
100.00%
-22.93
Landos Biopharma Inc (LABP) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
174.28%
0.491
|
-0.661 | 0.517 | 0.445 | - |
Operating Expenses
|
27.14%
6.61
|
5.199 | 4.439 | 6.479 | 6.513 |
Benefits Costs and Expenses |
27.14%
6.61
|
5.199 | 4.439 | 6.479 | - |
Costs And Expenses |
27.14%
6.61
|
5.199 | 4.439 | 6.479 | - |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
27.14%
-6.61
|
-5.199 | -4.439 | -6.479 | -6.513 |
Net Interest Income/Expense |
174.28%
0.491
|
-0.661 | 0.517 | 0.445 | - |
Interest Income/Expense After Provision For Losses |
174.28%
0.491
|
-0.661 | 0.517 | 0.445 | - |
Income/Loss From Continuing Operations Before Tax |
4.42%
-6.119
|
-5.86 | -3.922 | -6.034 | -5.232 |
Income/Loss From Continuing Operations After Tax |
4.42%
-6.119
|
-5.86 | -3.922 | -6.034 | -5.232 |
Net Income/Loss
|
4.42%
-6.119
|
-5.86 | -3.922 | -6.034 | -5.232 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
100.37%
-0.023
|
6.2076 | 6.2077 | 64.84 | - |
Diluted Average Shares |
100.37%
-0.023
|
6.2076 | 6.2077 | 64.84 | - |
Basic Earnings Per Share |
5.32%
-0.99
|
-0.94 | -0.63 | -0.09 | -0.13 |
Diluted Earnings Per Share |
5.32%
-0.99
|
-0.94 | -0.63 | -0.09 | -0.13 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):